This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Invitrogen
other brands :
NeoMarkers, Lab Vision, Endogen, Pierce, BioSource International, Zymed Laboratories, Caltag, Molecular Probes, Research Genetics, Life Technologies, Applied Biosystems, GIBCO BRL, ABgene, Dynal, Affinity BioReagents, Nunc, Invitrogen, NatuTec, Oxoid, Richard-Allan Scientific, Arcturus, Perseptive Biosystems, Proxeon, eBioscience
product type :
protein
product name :
Human EPB41L3 (aa 830-915) Control Fragment Recombinant Protein
catalog :
RP-93121
quantity :
100 uL
price :
US 259.00
product information
Product Type :
Protein
Product Name :
Human EPB41L3 (aa 830-915) Control Fragment Recombinant Protein
Catalog # :
RP-93121
Quantity :
100 uL
Price :
US 259.00
Clonality :
Recombinant
Purity :
purified
Reactivity :
Human
Applications :
Blocking Assay: Assay-dependent, Control: Assay-dependent
Species :
Human
Storage :
-20 C, Avoid Freeze/Thaw Cycles
Description :
Critical growth regulator in the pathogenesis of meningiomas. Its human homolog acts as a tumor suppressor and binds 14-3-3 proteins.
Format :
Liquid
Applications w/Dilutions :
Blocking Assay: Assay-dependent, Control: Assay-dependent
Aliases :
130kDa Protein 4.1B MEF cell isoform; 4.1B; 60kDa 4.1B MEF cell isoform; band 4.1-like protein 3; Band 4.1-like protein 3, N-terminally processed; Dal1; DAL-1; DAL1P; differentially expressed in adenocarcinoma of the lung protein 1; Epb4.1l3; Epb41l3; epb41l3.L; erythrocyte membrane protein band 4.1 like 3; erythrocyte membrane protein band 4.1-like 3; erythrocyte membrane protein band 4.1-like 3 L homeolog; erythrocyte protein band 4.1 like 3; erythrocyte protein band 4.1-like 3; FLJ37633; HGNC:3380; Kiaa0987; mDAL-1; NBL3; XELAEV_18031863mg
company information
Invitrogen
Thermo Fisher Scientific
81 Wyman Street
Waltham, MA USA 02451
https://www.thermofisher.com81 Wyman Street
Waltham, MA USA 02451
800-678-5599
headquarters: USA
questions and comments